GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

GSK and other drugmakers have lost no time in ... the UK’s voluntary scheme that covers branded medicines pricing and access. The pharma industry's challenge to Medicare drug price negotiation ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK has filed a pair of lawsuits against Moderna ... the UK’s voluntary scheme that covers branded medicines pricing and access. The pharma industry's challenge to Medicare drug price ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

The 2nd Microshort Drama Conference was held during November 5-7 in Linping District of Hangzhou City, east China's Zhejiang Province, gathering experts, industry leaders and enterprise ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...

She shared the moment it first became clear that Harry was Meghan’s “spare” claiming it was evident in the couple’s Time cover photo in 2021. Time Magazine names Prince Harry and Meghan ...